PT  - JOURNAL ARTICLE
AU  - Piantino, Juan A.
AU  - Ruzas, Christopher M.
AU  - Press, Craig A.
AU  - Subramanian, Subramanian
AU  - Balakrishnan, Binod
AU  - Panigrahy, Ashok
AU  - Pettersson, David
AU  - Maloney, John A.
AU  - Vossough, Arastoo
AU  - Topjian, Alexis
AU  - Kirschen, Matthew P
AU  - Doughty, Lesley
AU  - Chung, Melissa G.
AU  - Maloney, David
AU  - Haller, Tamara
AU  - Fabio, Anthony
AU  - Fink, Ericka L.
AU - the POCCA Investigators
TI  - Use of magnetic resonance imaging in neuroprognostication after pediatric cardiac arrest: Survey of current practices
AID  - 10.1101/2022.01.25.22269764
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.25.22269764
4099  - http://medrxiv.org/content/early/2022/01/25/2022.01.25.22269764.short
4100  - http://medrxiv.org/content/early/2022/01/25/2022.01.25.22269764.full
AB  - Background Use of MRI as a tool to aid in neuroprognostication after cardiac arrest (CA) has been described, yet details of specific indications, timing, and sequences are unknown. We aim to define the current practices in use of brain MRI in prognostication after pediatric cardiac arrest.METHODS A survey was distributed to pediatric institutions participating in three international studies. Survey questions related to center demographics, clinical practice patterns of MRI after CA, neuroimaging resources, and details regarding MRI decision support.RESULTS Response rate was 31% (44/143). Thirty-four percent (15/44) of centers have a clinical pathway informing the use of MRI after CA. Fifty percent (22/44) of respondents reported that an MRI is obtained in nearly all CA patients and 32% (14/44) obtain an MRI in those who did not return to baseline neurological status. Sixty-four percent of centers (28/44) obtain an MRI greater than 72 hours after return of spontaneous circulation. Poor neurologic exam was reported as the most common factor (91% [40/44]) determining the timing of the MRI. Conventional sequences (T1, T2, FLAIR, and diffusion weighted imaging/apparent diffusion coefficient) are widely used. Advanced imaging techniques, such as MR spectroscopy, diffusion tensor imaging and resting state functional MRI are less commonly used.CONCLUSIONS Conventional brain MRI is a common practice for prognostication after CA. Advanced imaging techniques, are used infrequently. The lack of standardized clinical pathways and variability in reported practices support a need for higher-quality evidence regarding the indications, timing, and acquisition protocols of clinical MRI studies.Competing Interest StatementDeclarations of Interest: Dr. Fink receives funding from National Institute of Neurological Disorders and Stroke (NINDS) R01NS096714; Neurocritical Care Society Incline Grant Dr. Piantino receives support from the National Institute of Health, National Heart, Lung, and Blood Institute; grant K23HL150217 Dr. Press has performed paid expert testimony and provides consulting for Marinus Pharmaceuticals The remainder of the authors have no relevant interests to disclose.Funding StatementJuan Piantino: National Heart, Lung, and Blood Institute (NHLBI) K23HL150217 Ericka Fink: National Institute of Neurological Disorders and Stroke (NINDS) R01NS096714Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the University of Pittsburgh Institutional Review Board as Not Human Research (STUDY20010055).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors